Contents
pdf Download PDF pdf Download XML
79 Views
37 Downloads
Share this article
Clinical Images | | Volume 4 Issue 3 (July-September, 2014) | Pages 153 - 154

Ovarian Metastasis Causing Huge Splenic Enlargement

 ,
 ,
1
Liaqat National Postgraduate Medical Centre, Karachi, Pakistan The Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
2
North Cumbria University Hospitals NHS Trust, Carlisle, United Kingdom
3
Liaqat National Postgraduate Medical Centre, Karachi, Pakistan
Under a Creative Commons license
Open Access
Received
Feb. 10, 2014
Accepted
May 27, 2014
Published
Sept. 30, 2014

Abstract

INTRODUCTION

 Parenchymal splenic metastasis is uncommon and has been reported to pose significant diagnostic and technical challenge [1]. We report a case of huge spleen with cystic metastasis of ovarian origin.

CASE REPORT

A 32-year-old woman presented with a large mass in the abdomen associated with significant discomfort, breathing difficulty, and impaired quality of life. Approximately three years ago, she was treated with neoadjuvant chemotherapy, abdominal hysterectomy, bilateral salpingo-oopherectomy, and omentectomy for ovarian adenocarcinoma with omental and para-aortic nodal metastases. Abdominal examination revealed marked distension with a large palpable mass. An elevation in CA-125 levels (233 U/mL) suggested recurrent ovarian cancer and a CT scan showed a large cystic mass arising from spleen, measuring 25×21 cm, and liver metastasis. In view of potential resectability of the mass, a palliative resection was offered to alleviate the symptoms. At laparotomy, spleen was noted to be transformed into a huge mass occupying most of the abdomen and measured 25×20 cm in size (Figure 1). The splenic mass was resected intact and the specimen weighed seven kilograms. The histological examination confirmed the metastasis from ovarian cystadenocarcinoma. The patient showed slow, but uncomplicated recovery. She was discharged home following ten days of hospital stay. She recovered fully from surgery and was well at two months follow up.

DISCUSSION

Spleen remains an infrequent site for metastatic disease with up to 0.6% and 7.3% of spleens showing malignant deposits at autopsy and pathological assessment, respectively [1, 2]. Direct peritoneal spread with capsular splenic metastases are not uncommon, however, parenchymal deposits are a relatively rare occurrence and represent hematogenous dissemination [1]. Most splenic metastases originate from tumours both above and below the diaphragm with ovarian cancer providing the commonest source [2, 3]. Open surgical resection is the mainstay of treatment if deemed operable. Splenic metastasis is indicative of aggressive distant disease with a generally poor prognosis.

None

  1. Ghani AA, Hashmi ZA, Chase DM, Patel SB, Jones DF. Intraparenchymal metastases to spleen from ovarian cancer: a case report. Journal of medical case reports. 2010;4(1):72. Epub 2010/02/26.
  2. Lam KY, Tang V. Metastatic tumors to the spleen: a 25-year clinicopathologic study. Arch Pathol Lab Med. 2000;124(4):526-30.
  3. Gatenby PA, Mudan SS, Wotherspoon AC. Splenectomy for non-haematological metastatic malignant disease. Langenbecks Arch Surg. 2011;396(5):625-38.
Recommended Articles
Research Article

Nurses' Perception Toward Therapeutic Strategies for Children with Pneumonia

...
Published: 16/11/2023
pdf Download PDF
Case Report

Intimal Flap Intussusception into the Innominate Artery of a Bovine-type Aortic Arch in a Acute Type-A Aortic Dissection: A Case Report

Published: 16/11/2023
pdf Download PDF
Research Article

Assessment of Serum Caspase-1, IL-10, and IL-18 Levels in Baghdad's Medical City in Women with Polycystic Ovary

...
Published: 16/11/2023
pdf Download PDF
Research Article

Prevalence of Face Mask-Induced Dry Eye and Ocular Irritation Amid COVID-19 Among Health Workers in Jazan

...
Published: 16/11/2023
pdf Download PDF
Review Article

Prevalence of Obstructive Sleep Apnea in Gulf Countries - A literature review

Published: 16/11/2023
pdf Download PDF
Copyright © Journal of Pioneering Medical Sciences until unless otherwise.